Literature DB >> 8105466

Enhancement of peptide antigen presentation by a second peptide.

A I de Kroon1, H M McConnell.   

Abstract

The influence of nonstimulatory "competitor" peptides on the binding of an antigenic peptide to a major histocompatibility complex (MHC) class II molecule was investigated. Using high-performance size-exclusion chromatography and fluorescein-labeled peptides, we show that the presence of the peptides dynorphin A-(1-13) and poly(L-lysine) results in enhancement rather than inhibition of the binding of hen egg lysozyme peptide-(107-116) [HEL-(107-116)] to the detergent-solubilized mouse class II molecule IEd. In parallel, dynorphin A-(1-13) and poly(L-lysine) were found to enhance the specific activation of an IEd-restricted T-cell hybridoma by HEL-(107-116). A molecular mechanism involving an intermediate two peptide-MHC class II protein complex is proposed to explain the enhancement of peptide binding to class II molecules by an irrelevant second peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105466      PMCID: PMC47447          DOI: 10.1073/pnas.90.19.8797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant.

Authors:  A Sette; S Ceman; R T Kubo; K Sakaguchi; E Appella; D F Hunt; T A Davis; H Michel; J Shabanowitz; R Rudersdorf
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

2.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

Authors:  P A Roche; P Cresswell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

3.  A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.

Authors:  S Sadegh-Nasseri; H M McConnell
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

4.  Structural requirements for the interaction between peptide antigens and I-Ed molecules.

Authors:  A Sette; L Adorini; E Appella; S M Colón; C Miles; S Tanaka; C Ehrhardt; G Doria; Z A Nagy; S Buus
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

5.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

Authors:  A Sette; S Buus; E Appella; J A Smith; R Chesnut; C Miles; S M Colon; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

7.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

8.  Interaction of an immunodominant epitope with Ia molecules in T-cell activation.

Authors:  L Adorini; A Sette; S Buus; H M Grey; M Darsley; P V Lehmann; G Doria; Z A Nagy; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.

Authors:  B Bogen; J D Lambris
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

10.  Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.

Authors:  H Bhayani; Y Paterson
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  8 in total

1.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Catalysis of peptide dissociation from class II MHC-peptide complexes.

Authors:  L Schmitt; J R Kratz; M M Davis; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

4.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II.

Authors:  C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.

Authors:  R G Urban; R M Chicz; J L Strominger
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

7.  An insulin peptide that binds an alternative site in class II major histocompatibility complex.

Authors:  S M Tompkins; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

Review 8.  HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Front Immunol       Date:  2013-10-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.